OTLK – outlook therapeutics, inc. (US:NASDAQ)
Stock Stats
News
11/6
08:05 am
otlk
Low
Outlook Therapeutics® to Present at the Guggenheim Healthcare Innovation Conference
10/18
11:53 am
otlk
Low
Outlook Therapeutics, Inc. (NASDAQ: OTLK) had its "buy" rating re-affirmed by analysts at BTIG Research. They now have a $50.00 price target on the stock.
10/17
09:00 am
otlk
Low
Outlook Therapeutics® Participates in a Virtual Investor CEO Connect Segment
10/11
09:00 pm
otlk
Low
OUTLOOK ALERT: Bragar Eagel & Squire, P.C. is Investigating Outlook Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
9/16
08:05 am
otlk
Medium
Outlook Therapeutics® to Participate in the Virtual Investor Closing Bell Series
8/14/2024
07:05 am
otlk
-5.3%
BEAT
5/15/2024
05:00 pm
otlk
-4.4%
MISS
2/14/2024
08:05 am
otlk
2.0%
BEAT
10/18
11:53 am
Reiterates
Buy
Buy
BTIG Research
Low
2.3%
10/18
11:21 am
Reiterates
Buy
Buy
BTIG
Medium
4.1%
9/3
06:15 am
Maintains
Buy
Buy
Ascendiant Capital
Medium
-7.7%
8/16
01:13 pm
Reiterates
Buy
Buy
Chardan Capital
Low
-0.6%
8/16
12:41 pm
Maintains
Buy
Buy
Chardan Capital
Low
-2.4%
11/7
04:22 pm
otlk
Medium
Form SC 13G/A Outlook Therapeutics, Filed by: Velan Capital Investment Management LP
10/3
09:23 pm
otlk
Low
Form 4 Outlook Therapeutics, For: Oct 01 Filed by: Gangolli Julian S
10/3
08:31 pm
otlk
Low
Form 4 Outlook Therapeutics, For: Oct 01 Filed by: Auffarth Gerd
10/3
08:31 pm
otlk
Low
Form 4 Outlook Therapeutics, For: Oct 01 Filed by: Haddadin Yezan Munther
10/3
08:31 pm
otlk
Low
Form 4 Outlook Therapeutics, For: Oct 01 Filed by: Haller Julia A
Show more
Top News Gainers
5/15 Form 10-Q Outlook Therapeutics, For: Mar 31 62.8%
12/31 Form 4 Outlook Therapeutics, For: Dec 31 Filed by: Pillai Arun Kumar 48.6%
2/24 Outlook Therapeutics Announces $10.2 Million Financings Priced At-The-Market 20.0%
12/3 Outlook Therapeutics Receives FDA Agreement for Three Special Protocol Assessments for Additional Planned Clinical Trials of ONS-5010 16.9%
7/18 Outlook Therapeutics, Inc. (NASDAQ: OTLK) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock. 14.8%
12/30 Form 4 Outlook Therapeutics, For: Dec 23 Filed by: Pillai Arun Kumar 13.5%
12/23 Form 8-K Outlook Therapeutics, For: Dec 20 11.3%
5/20 Outlook Therapeutics: A Perfect Storm Of Positive Catalysts Driving Share Price Up [Seeking Alpha] 11.1%
4/15 Outlook Therapeutics to Present at the April 2020 Virtual Investor Summit 9.2%
9/11 Outlook Therapeutics to Present at the 29th Annual Ladenburg Thalmann 2019 Healthcare Conference 7.3%
Top News Decliners
12/23 Outlook Therapeutics Announces Warrant Amendment and Restructuring of Senior Secured Notes in Separate Transactions -50.0%
1/28 Outlook Therapeutics Announces Agreements to Streamline Capital Structure and Regain 100% Ownership of Any Future Net Profits for ONS-5010 -15.0%
12/3 Outlook Therapeutics up 49% on advancement of ONS-5010 [Seeking Alpha] -14.0%
8/27 Outlook Therapeutics to Present at the H.C. Wainwright 21st Annual Healthcare Conference -12.6%
5/15 Q2/2019 3/31/2019 EPS -0.580 ZacksConsensus N/A ActVsEst N/A - N/A -9.9%
5/17 Outlook Therapeutics' stock rockets on heavy volume again, has more than doubled in 2 days [MarketWatch] -9.1%
9/18 Outlook Therapeutics, Inc. (NASDAQ: OTLK) was downgraded by analysts at Zacks Investment Research from a "strong-buy" rating to a "hold" rating. -9.0%
6/3 Form S-3 Outlook Therapeutics, -7.3%
2/24 Form 424B5 Outlook Therapeutics, -7.3%
6/14 Form 8-K Outlook Therapeutics, For: Jun 11 -7.3%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3